Orthostatic Symptoms in Women Treated with Low-Dose Oral Minoxidil in the Absence of Overt Hypotension: Implications for Clinical Practice

    Michael M Ong, Shari R. Lipner
    Studysummary Low-dose oral minoxidil can cause dizziness in women without lowering blood pressure, so careful monitoring is needed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Summation and Recommendations for the Safe and Effective Use of Topical and Oral Minoxidil Journal of the American Academy of Dermatology · 2025
    2. Gender Differences in Adverse Effects and Dosing Practices of Low-Dose Oral Minoxidil for Androgenetic Alopecia: A Retrospective Analysis of 310 Patients Skin Appendage Disorders · 2024
    3. Response to 'Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated With Clinically Significant Blood-Pressure Changes: A Retrospective Study' Journal of the American Academy of Dermatology · 2024
    4. Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated With Clinically Significant Blood-Pressure Changes: A Retrospective Study Journal of The American Academy of Dermatology · 2023

    Related research 8

    1. Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation Acta Dermato Venereologica · 2025
    2. Minoxidil Sulfotransferase Enzymatical Activity in Plants: A Novel Paradigm in Increasing Minoxidil Response in Androgenetic Alopecia Journal of Cosmetic Dermatology · 2023
    3. Tretinoin Enhances Minoxidil Response in Androgenetic Alopecia Patients by Upregulating Follicular Sulfotransferase Enzymes Dermatologic Therapy · 2019
    4. The Use of Minoxidil in the Treatment of Male and Female Androgenetic Alopecia: A Story of More Than 30 Years Italian journal of dermatology and venereology · 2018
    5. Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-Month Randomized Trial 2010
    6. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002
    7. Androgenetic Alopecia: Treatment Results with Topical Minoxidil Journal of The American Academy of Dermatology · 1987
    8. Topical Minoxidil Therapy and Hair Regrowth Archives of Dermatology · 1985